Innovative FEED Act of 2025
- Sponsor
- Rep. Langworthy, Nicholas A. [R-NY-23]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 18, 2025
Bottom line
The bill establishes a clearer, more efficient regulatory pathway for innovative animal feed additives that enhance animal health and production by acting within the digestive tract, distinguishing them from animal drugs.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to create a new regulatory category for 'zootechnical animal food substances.' These substances, which affect animal digestion, reduce foodborne pathogens, or alter the gastrointestinal microbiome, will be regulated as food additives rather than animal drugs, streamlining their approval process by the Food and Drug Administration (FDA).
Proponents argue
Proponents argue that the current regulatory framework for animal drugs is ill-suited for these types of feed ingredients, stifling innovation. They contend that this bill will foster economic development, improve animal health and welfare, and enhance food safety by accelerating the availability of beneficial products that act solely within the gastrointestinal tract.
Opponents contend
Critics may express concerns that reclassifying these substances as food additives, even with specific data requirements, could potentially lead to less rigorous safety and efficacy oversight compared to the animal drug approval process, potentially introducing products with unproven or unintended physiological effects into the food supply.
The bill is concise and relatively accessible for readers familiar with regulatory language, allowing for a quick yet thorough review.
Section 2(a), amending Section 201 of the FFDCA (21 U.S.C. 321)
Establishes New Definition for Zootechnical Animal Food Substances
This provision defines 'zootechnical animal food substance' as a substance added to animal food or water intended to affect digestive byproducts, reduce foodborne pathogens, or alter the gastrointestinal microbiome, acting solely within the animal's GI tract. It explicitly excludes substances for disease treatment, hormones, existing animal drugs, and ionophores.
Supporters argue
Supporters argue this definition provides necessary clarity and a distinct regulatory pathway for innovative feed ingredients that are not drugs, fostering innovation and improving animal health and food safety.
Critics contend
Critics might argue that creating a new category could inadvertently weaken oversight if not carefully implemented, potentially allowing substances with drug-like effects to bypass stricter drug approval processes.
Tradeoffs
This provision balances the desire for regulatory efficiency and innovation with the need to ensure animal and human food safety by carefully delineating what constitutes a zootechnical substance.
Section 2(a), amending Section 201(tt)(3) of the FFDCA
Zootechnical Substances Deemed Food Additives, Not Drugs
This section clarifies that a zootechnical animal food substance is considered a 'food additive' and must comply with food additive regulations (Section 409). Crucially, it specifies that such a substance is not considered an animal 'drug' solely because it has the intended effects described in the new definition, thus shifting its regulatory pathway.
Section 2(b)(1), amending Section 409(b) of the FFDCA
Specific Data Requirements for Zootechnical Food Additive Petitions
This amendment modifies the food additive petition requirements to specifically mandate that petitions for zootechnical animal food substances include 'all relevant data bearing on the effect the zootechnical animal food substance is intended to have and the quantity of such substance required to produce the intended effect,' along with 'full reports of investigations' regarding its intended use.
Section 2(b)(2), amending Section 409(c) of the FFDCA
Establishes Conditions for Approval and Denial of Zootechnical Substance Petitions
This provision modifies the conditions for FDA approval of food additives, specifically adding that for zootechnical substances, regulations must prescribe 'the conditions under which such substance may be used to achieve the intended effect.' It also adds a new explicit ground for denying a petition: if the substance 'fails to establish that the proposed use... will achieve the intended effect.'
Section 2(b)(3), amending Section 409 of the FFDCA; and Section 2(c), amending Section 403 of the FFDCA
Mandatory Labeling and Misbranding Provisions
This provision mandates that zootechnical animal food substances include the statement: 'Not for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals.' It also permits statements regarding the substance's intended effect on animal structure or function. Failure to include the mandatory statement will render the food misbranded under the FFDCA.
This section includes a rule of construction stating that nothing in the Act or its amendments shall be construed to authorize the Secretary of Health and Human Services to require the use of any zootechnical food substance or food additive.
Section 2(d)
Why it matters:This is standard legislative practice to include clarifying language that prevents potential misinterpretation or overreach by regulatory agencies, ensuring the bill focuses on voluntary market entry rather than mandates.
Case for: This provision ensures that the bill focuses solely on regulating substances that manufacturers choose to develop and market, rather than imposing their use. It protects industry autonomy and consumer choice by preventing the FDA from mandating the use of these substances.
Case against: There is no direct case against this clarifying provision, as it serves to prevent potential misinterpretation and overreach, which is generally seen as beneficial for regulatory predictability.
Estimated impact: Prevents potential overreach by the FDA in mandating the use of these substances, reinforcing the voluntary nature of their adoption by the animal agriculture industry.